Edwards Lifesciences Backtesting

Edwards Lifesciences Corporation -- USA Stock  

USD 139.07  2.27  1.61%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Edwards Lifesciences Corporation and determine expected loss or profit from investing in Edwards Lifesciences over given investment horizon. Additionally see Edwards Lifesciences Hype Analysis, Edwards Lifesciences Correlation, Edwards Lifesciences Valuation, Edwards Lifesciences Volatility as well as analyze Edwards Lifesciences Alpha and Beta and Edwards Lifesciences Performance
 Time Horizon     30 Days    Login   to change

Edwards Lifesciences 'What if' Analysis

February 19, 2018
No Change 0.00  0.0%
In 31 days
March 21, 2018
If you would invest  0.00  in Edwards Lifesciences on February 19, 2018 and sell it all today you would earn a total of 0.00 from holding Edwards Lifesciences Corporation or generate 0.0% return on investment in Edwards Lifesciences over 30 days. Edwards Lifesciences is related to or competes with Express Scripts, AmerisourceBergen, Baxter International, C R, and Becton Dickinson. Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill...

Edwards Lifesciences Upside/Downside Indicators


Edwards Lifesciences Market Premium Indicators

Edwards Lifesciences lagged returns against current returns

 Current and Lagged Values 

Edwards Lifesciences regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Edwards Lifesciences Backtested Returns

We consider Edwards Lifesciences not too risky. Edwards Lifesciences secures Sharpe Ratio (or Efficiency) of 0.1642 which denotes Edwards Lifesciences had 0.1642% of return per unit of risk over the last 1 month. Our philosophy towards predicting volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Edwards Lifesciences Corporation which you can use to evaluate future volatility of the firm. Please confirm Edwards Lifesciences Coefficient Of Variation of 608.9, Mean Deviation of 0.7841 and Downside Deviation of 1.19 to check if risk estimate we provide are consistent with the epected return of 0.1628%. Edwards Lifesciences has performance score of 10 on a scale of 0 to 100. The firm shows Beta (market volatility) of -0.1549 which denotes to the fact that as returns on market increase, returns on owning Edwards Lifesciences are expected to decrease at a much smaller rate. During bear market, Edwards Lifesciences is likely to outperform the market.. Although it is extremely important to respect Edwards Lifesciences historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By reviewing Edwards Lifesciences technical indicators you can presently evaluate if the expected return of 0.1628% will be sustainable into the future. Edwards Lifesciences right now shows a risk of 0.9912%. Please confirm Edwards Lifesciences Information Ratio, Potential Upside as well as the relationship between Potential Upside and Kurtosis to decide if Edwards Lifesciences will be following its price patterns.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.16 

Very weak predictability

Edwards Lifesciences Corporation has very weak predictability. Overlapping area represents the amount of predictability between Edwards Lifesciences time series from February 19, 2018 to March 6, 2018 and March 6, 2018 to March 21, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Edwards Lifesciences price movement. The serial correlation of 0.16 indicates that over 16.0% of current Edwards Lifesciences price fluctuation can be explain by its past prices.
Correlation Coefficient 0.16
Spearman Rank Test 0.05
Price Variance 2.15
Lagged Price Variance 2.02

Edwards Lifesciences Lagged Returns

 Regressed Prices 

Edwards Lifesciences Performance vs DOW

The median price of Edwards Lifesciences for the period between Mon, Feb 19, 2018 and Wed, Mar 21, 2018 is 137.85 with a coefficient of variation of 2.14. The daily time series for the period is distributed with a sample standard deviation of 2.94, arithmetic mean of 137.52, and mean deviation of 2.55. The Stock received some media coverage during the period.
 Price Growth (%)  
Sale by Donald Bobo of 8000 shares of Edwards Lifesciences02/27/2018
As Viacom New Stock Price Declined, Yakira Capital Managemen...03/21/2018